News

March 6, 2026

SyVento BioTech is pleased to announce our participation in the upcoming World Vaccine Congress USA, taking place from 31 March to 2 April 2026 in Washington, D.C. This global forum brings together leading experts advancing the future of vaccine innovation, development and manufacturing. At SyVento BioTech, we support next generation vaccine and therapeutic programs with […]

March 4, 2026

With only one month left until the 5th LNP Formulation and Process Development Summit begins in Boston, SyVento BioTech is preparing to join this leading global forum focused on advancing lipid nanoparticle science. Taking place from 6 April to 8 April 2026, the summit will bring together experts driving innovation in LNP formulation, analytical development […]

February 23, 2026

From 23–25 March 2026, industry leaders will gather in Lisbon for one of the most influential partnering events in the biotech and pharma calendar. For SyVento BioTech, this is a valuable opportunity to strengthen international collaborations, explore new strategic partnerships, and showcase how our integrated CDMO services can support next‑generation therapeutics. BIO-Europe Spring offers an […]

February 18, 2026

In just one month, we will be heading to RNA Leaders Europe 2026 taking place on 18–19 March in Vienna. We’re excited to join leading experts and innovators shaping the rapidly evolving world of RNA therapeutics. SyVento BioTech will be represented by: Eliza Milewicz, SVP, Chief Commercial Officerand Dominik Lipka, Chief Technology Officer. This event […]

December 15, 2025

  Mabion S.A. and SyVento sp. z o.o. announce the signing of a Letter of Intent to establish cooperation in the manufacturing of a medicinal product. Under the planned collaboration, SyVento will provide aseptic fill and finish services for the drug product on behalf of Mabion, in pre-filled syringe (PFS) and cartridge formats. These fill […]

November 7, 2025

We are excited to announce that SyVento BioTech will be participating in the 13th mRNA Health Conference in Berlin! This annual event will take place on 11-13 November, bringing together leading experts in hasztag#mRNA science and we are proud to be part of this important dialogue. Our representatives, Dominik Lipka PhD Eng. – CTO, and […]

November 5, 2025

Join us next week at TIDES: Oligonucleotides and Peptide Therapeutics in Basel! SyVento BioTech will be represeted by Anna Michalska and Andreas Stocker who will be more than happy to discuss potential collaboration. We offer hasztag#CDMO services for preclinical and clinical drug development, GMP manufacturing and aseptic fill & finish. Our expertise includes mRNA/LNP technologies […]

October 27, 2025

As October turns into November, exciting weeks are ahead for SyVento BioTech! While we are finalizing preparations for CPHI Milan (booth #3.1H80A) we are also eagerly looking forward to hasztag#BIOEurope, taking place 3–5 November in Vienna, Austria. BIO-Europe is one of the leading partnering conferences for the global biotech and pharmaceutical industry – where innovation, […]

October 3, 2025

At the end of this month, the global pharma community will gather for CPHI Milan 2025 – and SyVento BioTech is looking forward to be part of it. We specialize in comprehensive hasztag#CDMO services for pharma and biotech innovatiors, offering preclinical/clinical drug development, RUO/GMP-grade mRNA synthesis, manufacturing of GMP commercial/clinical batches, and aseptic fill & […]